中国血液净化

中国血液净化 ›› 2022, Vol. 21 ›› Issue (10): 713-718.doi: 10.3969/j.issn.1671-4091.2022.10.003

• 一切为了人民健康--我们这十年·专题讲座 • 上一篇    下一篇

碘对比剂对透析患者残余肾功能影响的研究进展

金瀚拿   赵慧萍    王 梅   

  1. 100044 北京，1北京大学人民医院肾内科
  • 收稿日期:2022-04-29 修回日期:2022-05-12 出版日期:2022-10-12 发布日期:2022-10-12
  • 通讯作者: 赵慧萍 E-mail:huipingzhao2009@163.com

Research Progress on the effect of iodine contrast media on residual renal function in dialysis patients  

KIM Hanna, ZHAO Hui-ping, WANG Mei   

  1. Department of Nephrology, Peking University People's Hospital, Beijing 100044, China
  • Received:2022-04-29 Revised:2022-05-12 Online:2022-10-12 Published:2022-10-12
  • Contact: 100044 北京，1北京大学人民医院肾内科 E-mail:huipingzhao2009@163.com

PDF

311

摘要： 透析患者的残余肾功能(residual renal function，RRF)与患者生存密切相关，避免加重肾损伤的因素是保护透析患者RRF的主要策略。随着透析患者的透析龄不断延长，涉及到血管介入检查、治疗的患者日渐增多。碘对比剂(Iodine contrast media,ICM)的应用可能导致急性肾损伤(acute kidney injury,AKI)的发生，但ICM对透析患者残余肾功能的影响如何？本文将就这一问题的研究进展做一综述。

关键词: 碘对比剂, 透析, 残余肾功能

Abstract: Residual renal function (RRF) is closely associated with increased survival in dialysis patients. Avoiding the factors aggravating renal injury is the main strategy to protect RRF of dialysis patients. With the continuous extension of dialysis duration，more patients are involved in vascular interventional examination and treatment. The application of iodine contrast media (ICM) may lead to acute kidney injury (AKI). However, how does ICM affect the RRF of dialysis patients? This paper reviews the research progress of the effect of ICM on RRF in dialysis patients.

Key words: Iodine contrast media； , Residual renal function； Peritoneal dialysis

中图分类号: